Investigation into the sources of superoxide in human blood vessels: Angiotensin II increases superoxide production in human internal mammary arteries

Circulation

Volumn 101, Issue 18, 2000, Pages 2206-2212

  Berry, Colin ^a   Hamilton, Carlene A ^a   Brosnan, M Julia ^a   Magill, Fergus G ^a   Berg, Geoffrey A ^a   McMurray, John J V ^a   Dominiczak, Anna F ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Angiotensin; Arteries; Free radicals; Receptors; Veins

Indexed keywords

ALLOPURINOL; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN ANTAGONIST; ENZYME INHIBITOR; LOSARTAN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE; SUPEROXIDE DISMUTASE; XANTHINE OXIDASE;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; INTERNAL MAMMARY ARTERY; MEDIATOR RELEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SAPHENOUS VEIN;

EID: 0034625073     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.101.18.2206     Document Type: Article

References (31)

1. Rubanyi GM, Vanhoutte PM. Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. Am J Physiol. 1986;250: H822-H827.
2. Grunfeld S, Hamilton CA, Mesaros S, McClain SW, Dominiczak AF, Bohr DF, Malinski T. Role of superoxide in the depressed nitric oxide production by the endothelium of genetically hypertensive rats. Hypertension. 1995;26:854-857.
3. Hamilton CA, Berg G, McIntyre M, McPhadden, Reid JL, Dominiczak AF. Effects of nitric oxide and superoxide on relaxation in human artery and vein. Atherosclerosis. 1997;133:77-86.
4. Panza JA, Casino PR, Kilcoyne CM, Quyumi AA. Role of endothelial-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med. 1990; 323:22-27.
5. Creager MA, Cooke JP, Mendelson ME, Gallagher SJ, Coleman SM, Loscalzo J, Dzau VJ. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest. 1990;86:228-234.
6. Calver A, Collier J, Vallance P. Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes. J Clin Invest. 1992;90:2548-2554.
7. Kubo S, Rector TS, Bank AJ, Williams RE, Heifetz SM. Endothelium-dependent vasodilation is attenuated in patients with heart failure. Circulation. 1991;84:1589-1596.
8. Kerr SM, Brosnan MJ, McIntyre M, Reid JL, Dominiczak AF, Hamilton CA. Superoxide anion production is increased in a model of genetic hypertension: the role of the endothelium. Hypertension. 1999;33: 1353-1358.
9. Miller FJ, Gutterman DD, Rios CD, Heistad DD, Davidson BL. Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis. Circ Res. 1998; 82:1298-1305.
10. Wang HD, Pagano PJ, Du Y, Cayatte AJ, Quinn MT, Brecher P, Cohen RA. Superoxide anion from the adventitia of the rat thoracic aorta inactivates nitric oxide. Circ Res. 1998;82:810-818.
11. Mohazzab-HK, Kaminski PM, Wolin MS. NADH oxidoreductase is a major source of superoxide anion in bovine coronary artery endothelium. Am J Physiol. 1994;266:H2568-H2572.
12. O'Hara Y, Peterson TE, Harrison DG. Hypercholesterolemía increases endothelial superoxide production. J Clin Invest. 1993;91:2546-2551.
13. McIntyre M, Hamilton CA, Rees DD, Reid JL, Dominiczak AF. Sex differences in the abundance of endothelial nitric oxide in a model of genetic hypertension. Hypertension. 1997;30:1517-1524.
14. Brawn K, Fridovich I. Superoxide radical and superoxide dismutase. Acta Physiol Scand. 1980;492:9-18.
15. Li Y, Huang TT, Carlson EJ, Melov S, Ursell PC, Olson JL, Noble LJ, Yoshimura MP, Berger C, Chan PH, Wallace DC, Epstein CJ. Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat Genet. 1995;11:376-381.
16. Griendling K, Candace MA, Ollerenshaw JD, Alexander WR. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res. 1994;74:1141-1148.
17. Rajagopalan S, Kurz S, Munzel T, Tarpey M, Freeman BA, Griendling KK, Harrison DG. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation: contribution to alterations of vasomotor tone. J Clin Invest. 1996;97:1916-1923.
18. Pagano PJ, Clark JK, Cifuentes-Pagano ME, Clark SM, Callis GM, Quinn MT. Localization of a constitutively active, phagocyte-like NADPH oxidase in rabbit aortic adventitia: enhancement by angiotensin II. Proc Natl Acad Sci U S A. 1997;94:14483-14488.
19. Huraux C, Makita T, Kurz S, Yamaguchi K, Szlam F, Tarpey MM, Wilcox JN, Harrison DG, Levy JH. Superoxide production, risk factors, and endothelium-dependent relaxations in human internal mammary arteries. Circulation. 1999;99:53-59.
20. Li Y, Zhu H, Kuppausamy P, Roubaud V, Zweier JL, Trush MA. Validation of lucigenin (bis-N-methylacidinium) as a chemilucigeninic probe for detecting superoxide anion radical production by enzymatic and cellular subsystems. J Biol Chem. 1998;273:2015-2023.
21. Skatchov MP, Sperling D, Hink U, Mulsch A, Harrison DG, Sindermann I, Meinertz T, Munzel T. Validation of lucigenin as a chemiluminescent probe to monitor vascular superoxide as well as basal nitric oxide production. Biochem Biophys Res Commun. 1999;254:319-324.
22. Oury T, Day BJ, Crapo JD. Extracellular superoxide dismutase in vessels of airways of humans and baboons. Free Radic Biol Chem. 1996;20: 957-965.
23. Phan SH, Gannon DE, Varani J, Ryan US, Ward PA. Xanthine oxidase activity in rat pulmonary artery endothelial cells and its alteration by activated neutrophils. Am J Pathol. 1989;134:1201-1211.
24. Cardillo C, Kilcoyne CM, Cannon RO, Quyyumi AA, Panza JA. Xanthine oxidase inhibition with oxypurinol improves endothelial vasodilator function in hypercholesterolemic but not in hypertensive patients. Hypertension. 1997;30:57-63.
25. Feenstra QL, Pfaffendorf M, Eijsman L, van Zwieten PA. Comparative vasoconstrictor effects of angiotensin II, III and IV in human isolated saphenous vein. J Cardiovasc Pharmacol. 1997;29:451-456.
26. Borland JA, Chester AH, Yacoub MH. Enhanced vasoreactivity of the human saphenous vein to angiotensin I and II: implications for its performance as a bypass graft. J Thorac Cardiavasc Surg. 1998;116: 206-212.
27. Toda N, Mityazaki M. Angiotensin induced relaxation in isolated dog renal and cerebral arteries. Am J Physiol. 1981;240:H247-H254.
28. Marumo T, Schini-Kerth VB, Brandes RP, Busse BR. Glucocorticoids inhibit superoxide anion production and p22 phox mRNA expression in human aortic smooth muscle cells. Hypertension. 1998;32:1083-1088.
29. Dikjkhorst LT, Stroes ESG, Koomans HA, Rabelink TJ. Acute simultaneous stimulation of nitric oxide and oxygen radicals by angiotensin II in humans in vivo. J Cardiovasc Pharmacol. 1999;33:420-424.
30. Jaimes EA, Galceran JM, Raij L. Angiotensin II induces superoxide production by mesangial cells. Kidney Int. 1998;54:775-784.
31. phox mRNA expression and NADPH oxidase superoxide generation in rabbit aortic adventitial fibroblasts. Hypertension. 1998;32: 331-337.